Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2025-12-25 @ 2:54 PM
NCT ID:
NCT03214250
Group ID:
EG004
Title:
Gem/NP/Nivolumab/APX005M (0.3 mg/kg)
Description:
Gemcitabine+Nab-Paclitaxel+nivolumab+APX005M (0.3 mg/kg)
APX005M: Administer intravenously once every 28-day Cycle
Nivolumab: Administer intravenously twice every 28-day cycle
Nab-Paclitaxel: Administer intravenously on 3 times every 28-day cycle
Gemcitabine: Administer intravenously 3 times every 28-day cycle
Deaths Number Affected:
27
Deaths Number At Risk:
None
Serious Number Affected:
20
Serious Number At Risk:
35
Other Number Affected:
35
Other Number At Risk:
35
Study:
NCT03214250
Results Section:
NCT03214250
Adverse Events Module:
NCT03214250